Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Blankenstein

Showing results (51-60 of 157) with videos related to

Pageof 16
Sort By:
Clinical Endocrinology|October 1, 1992
High affinity growth hormone binding protein in plasma of patients with acromegaly and the effect of octreotide treatmentC A Roelen, G H Donker, J H Thijssen, et al.
Prenatal Diagnosis|February 27, 2010
First trimester maternal serum ADAM12s levels in twin pregnanciesI H Linskens, J W R Twisk, M A Blankenstein, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum|January 1, 1988
Hormone receptors in human prostate cancerM A Blankenstein, J Bolt-de Vries, O G van Aubel, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|January 1, 1989
A prospective study on corpus luteum function and breast cancer riskI den Tonkelaar, M A Blankenstein, H J Collette, et al.
Breast Cancer Research and Treatment|January 1, 1984
Prolactin concentration in plasma and susceptibility to mammary tumors in female rats from different strains treated chronically with estradiol-17 betaM A Blankenstein, J J Broerse, M J van Zwieten, et al.
Cancer|September 1, 1996
Radioresistance and p53 status of T2 laryngeal carcinoma. Analysis by immunohistochemistry and denaturing gradient gel electrophoresisA Kropveld, P J Slootweg, A D van Mansfeld, et al.
Metabolism: Clinical and Experimental|August 1, 1993
The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistanceB J Potter van Loon, C Kluft, J K Radder, et al.
The Prostate|January 1, 1993
Effect of culture conditions on androgen sensitivity of the human prostatic cancer cell line LNCaPE G Langeler, C J van Uffelen, M A Blankenstein, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1995
Expression of the gene encoding growth hormone in the human mammary glandJ A Mol, S C Henzen-Logmans, P Hageman, et al.
The Journal of Steroid Biochemistry and Molecular Biology|August 7, 2002
Effect of tibolone (Org OD14) and its metabolites on aromatase and estrone sulfatase activity in human breast adipose stromal cells and in MCF-7 and T47D breast cancer cellsJ van de Ven, G H Donker, M Sprong, et al.
Pageof 16

Showing results (51-60 of 157) with videos related to

Sort By:
Pageof 16
Clinical Endocrinology|October 1, 1992
High affinity growth hormone binding protein in plasma of patients with acromegaly and the effect of octreotide treatmentC A Roelen, G H Donker, J H Thijssen, et al.
Prenatal Diagnosis|February 27, 2010
First trimester maternal serum ADAM12s levels in twin pregnanciesI H Linskens, J W R Twisk, M A Blankenstein, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum|January 1, 1988
Hormone receptors in human prostate cancerM A Blankenstein, J Bolt-de Vries, O G van Aubel, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|January 1, 1989
A prospective study on corpus luteum function and breast cancer riskI den Tonkelaar, M A Blankenstein, H J Collette, et al.
Breast Cancer Research and Treatment|January 1, 1984
Prolactin concentration in plasma and susceptibility to mammary tumors in female rats from different strains treated chronically with estradiol-17 betaM A Blankenstein, J J Broerse, M J van Zwieten, et al.
Cancer|September 1, 1996
Radioresistance and p53 status of T2 laryngeal carcinoma. Analysis by immunohistochemistry and denaturing gradient gel electrophoresisA Kropveld, P J Slootweg, A D van Mansfeld, et al.
Metabolism: Clinical and Experimental|August 1, 1993
The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistanceB J Potter van Loon, C Kluft, J K Radder, et al.
The Prostate|January 1, 1993
Effect of culture conditions on androgen sensitivity of the human prostatic cancer cell line LNCaPE G Langeler, C J van Uffelen, M A Blankenstein, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1995
Expression of the gene encoding growth hormone in the human mammary glandJ A Mol, S C Henzen-Logmans, P Hageman, et al.
The Journal of Steroid Biochemistry and Molecular Biology|August 7, 2002
Effect of tibolone (Org OD14) and its metabolites on aromatase and estrone sulfatase activity in human breast adipose stromal cells and in MCF-7 and T47D breast cancer cellsJ van de Ven, G H Donker, M Sprong, et al.
Pageof 16